Commercial assay for hepatitis C virus RNA

Peter Tilston; David J. Morris; Paul E. Klapper; Gerald Corbitt

doi:10.1016/S0140-6736(94)92809-6

Commercial assay for hepatitis C virus RNA

Peter Tilston^*, David J. Morris, Paul E. Klapper, Gerald Corbitt

^*Corresponding author for this work

Division of Immunology, Immunity to Infection and Respiratory Medicine

Booth Hall Children's Hospital

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	201-202
Number of pages	2
Journal	The Lancet
Volume	344
Issue number	8916
DOIs	https://doi.org/10.1016/S0140-6736(94)92809-6
Publication status	Published - 16 Jul 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(94)92809-6

Cite this

@article{a42f831e527847c2aa58d4a1e880118e,

title = "Commercial assay for hepatitis C virus RNA",

author = "Peter Tilston and Morris, {David J.} and Klapper, {Paul E.} and Gerald Corbitt",

year = "1994",

month = jul,

day = "16",

doi = "10.1016/S0140-6736(94)92809-6",

language = "English",

volume = "344",

pages = "201--202",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "8916",

}

TY - JOUR

T1 - Commercial assay for hepatitis C virus RNA

AU - Tilston, Peter

AU - Morris, David J.

AU - Klapper, Paul E.

AU - Corbitt, Gerald

PY - 1994/7/16

Y1 - 1994/7/16

UR - http://www.scopus.com/inward/record.url?scp=0028775306&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(94)92809-6

DO - 10.1016/S0140-6736(94)92809-6

M3 - Letter

C2 - 7912802

AN - SCOPUS:0028775306

SN - 0140-6736

VL - 344

SP - 201

EP - 202

JO - The Lancet

JF - The Lancet

IS - 8916

ER -

Commercial assay for hepatitis C virus RNA

UN SDGs

Access to Document

Other files and links

Cite this